Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
Pupil Premiums have featured in the headlines this week with Nick Clegg announcing the three schools who are winners of his Pupil Premium Awards. Each school took home cash rewards of up to £10,000 in recognition of the way they have pioneered the use of the Pupil Premium.
This announcement comes days after Ofsted's proposals to downgrade schools in which disadvantaged students failed to make good progress were reported. Under the new plan to focus on students receiving Pupil Premium funding, Ofsted inspectors will have to consider the differences in academic achievement between disadvantaged students and their non-disadvantaged peers. Ofsted is now unlikely to rate any school as outstanding if it has a wide attainment gap or if disadvantaged students are making poor progress.
With the Pupil Premium currently on both Nick Clegg’s and Ofsted’s agendas, it should probably also feature as a standing item on governing body agendas so that due attention can be given to the attainment of students in receipt of the Pupil Premium.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Associate
Select which mailings you would like to receive from us.
Sign up